130 related articles for article (PubMed ID: 27077040)
21. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
Gilson P; Franczak C; Dubouis L; Husson M; Rouyer M; Demange J; Perceau M; Leroux A; Merlin JL; Harlé A
PLoS One; 2019; 14(7):e0219204. PubMed ID: 31265477
[TBL] [Abstract][Full Text] [Related]
23. Comparison of manual and automated AmpliSeq™ workflows in the typing of a Somali population with the Precision ID Identity Panel.
van der Heijden S; de Oliveira SJ; Kampmann ML; Børsting C; Morling N
Forensic Sci Int Genet; 2017 Nov; 31():118-125. PubMed ID: 28938152
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq™ panel.
Kringel D; Sisignano M; Zinn S; Lötsch J
PLoS One; 2017; 12(6):e0180116. PubMed ID: 28658281
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
[TBL] [Abstract][Full Text] [Related]
26. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
Neves RP; Raba K; Schmidt O; Honisch E; Meier-Stiegen F; Behrens B; Möhlendick B; Fehm T; Neubauer H; Klein CA; Polzer B; Sproll C; Fischer JC; Niederacher D; Stoecklein NH
Clin Chem; 2014 Oct; 60(10):1290-7. PubMed ID: 25267515
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous genomic identification and profiling of a single cell using semiconductor-based next generation sequencing.
Watanabe M; Kusano J; Ohtaki S; Ishikura T; Katayama J; Koguchi A; Paumen M; Hayashi Y
Appl Transl Genom; 2014 Sep; 3(3):70-7. PubMed ID: 27294018
[TBL] [Abstract][Full Text] [Related]
28. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
29. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
30. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
31. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
32. A novel approach for next-generation sequencing of circulating tumor cells.
Yee SS; Lieberman DB; Blanchard T; Rader J; Zhao J; Troxel AB; DeSloover D; Fox AJ; Daber RD; Kakrecha B; Sukhadia S; Belka GK; DeMichele AM; Chodosh LA; Morrissette JJ; Carpenter EL
Mol Genet Genomic Med; 2016 Jul; 4(4):395-406. PubMed ID: 27468416
[TBL] [Abstract][Full Text] [Related]
33. BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes.
Kechin A; Khrapov E; Boyarskikh U; Kel A; Filipenko M
Comput Biol Chem; 2018 Dec; 77():297-306. PubMed ID: 30408727
[TBL] [Abstract][Full Text] [Related]
34. Next generation sequencing with a semi-conductor technology (Ion Torrent PGM™) for HLA typing: overall workflow performance and debate.
Moalic-Allain V; Mercier B; Gueguen P; Ferec C
Ann Biol Clin (Paris); 2016 Aug; 74(4):449-56. PubMed ID: 27492698
[TBL] [Abstract][Full Text] [Related]
35. A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
Ferrarini A; Forcato C; Buson G; Tononi P; Del Monaco V; Terracciano M; Bolognesi C; Fontana F; Medoro G; Neves R; Möhlendick B; Rihawi K; Ardizzoni A; Sumanasuriya S; Flohr P; Lambros M; de Bono J; Stoecklein NH; Manaresi N
PLoS One; 2018; 13(3):e0193689. PubMed ID: 29494651
[TBL] [Abstract][Full Text] [Related]
36. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
[TBL] [Abstract][Full Text] [Related]
37. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
[TBL] [Abstract][Full Text] [Related]
38. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
Latteyer S; Tiedje V; König K; Ting S; Heukamp LC; Meder L; Schmid KW; Führer D; Moeller LC
Endocrine; 2016 Dec; 54(3):733-741. PubMed ID: 27696251
[TBL] [Abstract][Full Text] [Related]
39. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
[TBL] [Abstract][Full Text] [Related]
40. A next-generation-sequencing panel for mutational analysis of dominant acute hepatic porphyrias.
Barman-Aksözen J; Suter L; Wegmann F; Meienberg J; Minder AE; Beer M; Komminoth P; Minder EI; Schneider-Yin X
Scand J Clin Lab Invest; 2019 Sep; 79(5):305-313. PubMed ID: 31154864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
